Spero raises $51.7M in series C

By Chris Lieu | Mar 8, 2017 | 11:21 PM GMT

Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) raised $51.7 million

Read the full 101 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE